Tandem Diabetes (TNDM) Tops Q1 EPS by 8c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus

Go back to Tandem Diabetes (TNDM) Tops Q1 EPS by 8c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 17.55 +0.68 (4.03%)
Previous Close $16.87    52 Week High $12.48 
Open $17.01    52 Week Low $1.60 
Day High $17.62    P/E N/A 
Day Low $16.60    EPS $-6.33 
Volume 267,435